Francesco Draetta
InvestorPartner at Omega Funds
Boston, Massachusetts
Writes $100K β $5M checks Β· typically $1.5M
FoundedThird Arc Bio
Experience
- Omega FundsManaging Directorcurrent2024 β present
- Omega FundsPartner2021 β 2024Boston, MA, USA
- Omega FundsPrincipal2018 β 2021Boston, MA, USA
- Omega FundsSenior Associate2016 β 2018Boston, MA, USA
- Marea TherapeuticsBoard Observercurrent2024 β present
- ARTBIOBoard Observercurrent2022 β present
- NRG TherapeuticsBoard Directorcurrent2022 β present
- Third Arc BioBoard Directorcurrent2022 β present
- Kestra Medical Technologies, Inc.Board Director2024 β 2025
- Beta BionicsBoard Director2023 β 2024
- LEXEO TherapeuticsBoard Observer2020 β 2023
- Omega Alpha SPACChief Financial Officer2020 β 2023
- Amunix PharmaceuticalsBoard Observer2020 β 2022
- CHORD TherapeuticsBoard Director2020 β 2022
- Attenua, Inc.Board Observer2018 β 2020
- Brookside Mezzanine PartnersAnalyst2015 β 2016Stamford, CT, USA
- uConnect, Inc.Finance & Operations2014 β 2016Boston, MA, USA
- Commonfund CapitalAssociate2012 β 2014Wilton, CT, USA
- Omega FundsAnalyst2008 β 2012Boston, MA, USA
- Index VenturesSummer Analyst2008Geneva, Switzerland
Education
- Isenberg School of Management, UMass AmherstBachelor of Business Administration, Finance
- American School of MilanHigh School
- Startup InstituteTechnical Marketing
Skills & more
StrategyVenture CapitalInvestmentsBiotechnologyInvestor RelationsFinancial AnalysisFinancial ModelingCRMAlternative InvestmentsInvestment ManagementAsset ManagementHealthcare
Languages English Β· Italian
- Financial Risk Manager (FRM) β Global Association of Risk Professionals (GARP)
- Chartered Financial Analyst (CFA) β CFA Institute
- Chartered Alternative Investment Analyst (CAIA) β CAIA Association
From Francesco's professional profile.
Same school
Also attended Isenberg School of Management, UMass Amherst43
Paul ConwayInvestor at Spark CapitalKelly O'KaneInvestor at IVP (Institutional Venture Partners)Dr. Shadi BatahResearch / Founder Relations at Transform Capital ManagementHannah DitmarsAnalyst at Volition CapitalAllyson GallagherAccounting Manager at Volition CapitalAshley HardingOperations Specialist at Volition Capital
+ 37 more
Shared employers
Also worked at Beta Bionics1
Also worked at Commonfund Capital3
Also worked at Merrill Lynch405
Hans TungManaging Partner at Notable CapitalAnthony LinHead of Intel Capital, Corporate Vice President at Intel CapitalNoorPartner at Clear VenturesKesha CashFounder & General Partner at Impact America FundAftab MathurManaging Director at Temasek at Golden Gate VenturesAndrew WallaceVice President, Revolution Growth at Revolution
+ 399 more
Colleagues at Omega Funds
Alex Delbridge
Senior Associate at Omega Funds
Annie Mitsak
Partner at Cure Ventures
Benjamin Youn
Associate at Omega Funds
Bernard Davitian
Partner at Omega Funds
Claudio Nessi
Managing Director at Omega Funds
Deirdre Cunnane
COO, General Counsel at Omega Funds
Katie Kerfoot
Vice President at Omega Funds
Marla Jalbut
Associate at Omega Funds
Network6
Alex Delbridge
Senior Associate at Omega Funds
Annie Mitsak
Partner at Cure Ventures
Bernard Davitian
Partner at Omega Funds
Katie Kerfoot
Vice President at Omega Funds
Michael Powell
Partner at Omega Funds
Thomas Goebel
Principal at Omega Funds
Investors connected to Francesco in public investor directories β a warm-intro map.













%20(1).png)


